Replimune REPL
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$0.00
Operating profit-$56.04M+33.2% YoY
Net profit-$57.12M+31.3% YoY
Diluted EPS-$0.54+40.0% YoY
Free cash flow-$47.78M+42.1% YoY
Operating cash flow-$47.70M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-115.8%
Return on assets-71.0%
Return on invested capital-77.4%
Current ratio7.11
Liabilities / assets45.2%
Cash & investments$307.83M
Total debt$123.15M
Net cash (debt)$184.68M
Income statement
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $56.04M | $67.95M | $318.32M | $72.87M | $71.53M |
| Selling and Admin Expenses | $21.92M | $18.97M | $98.74M | $21.01M | $18.73M |
| Research & Development | $34.37M | $49.28M | $221.18M | $52.32M | $53.14M |
| Other Operating Expenses | -$238,000.00 | -$296,000.00 | -$1.60M | -$466,000.00 | -$341,000.00 |
| Operating Profit | -$56.04M | -$67.95M | -$318.32M | -$72.87M | -$71.53M |
| Net Non-Operating Interest Income (Expense) | -$3.03M | -$3.09M | -$8.86M | -$2.88M | -$1.98M |
| Non-Operating Interest Expense | $3.03M | $3.09M | $8.86M | $2.88M | $1.98M |
| Other Income (Expense) | $1.95M | $1.27M | $12.68M | $2.29M | $2.27M |
| Gain on Sale of Security | $1.88M | $1.96M | $13.63M | $2.37M | $2.85M |
| Other Non-Operating Income (Expenses) | $67,000.00 | -$688,000.00 | -$942,000.00 | -$77,000.00 | -$580,000.00 |
| Pretax Profit | -$57.12M | -$69.77M | -$314.49M | -$73.46M | -$71.24M |
| Net Profit | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| Profit from Continuing Operations | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| Net Income to Parent Company | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| Net Income to Common Stockholders | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| Basic EPS | -$0.54 | -$0.72 | -$3.38 | -$0.76 | -$0.77 |
| Diluted EPS | -$0.54 | -$0.72 | -$3.38 | -$0.76 | -$0.77 |
| Tax | – | – | -$551,000.00 | -$240,000.00 | -$311,000.00 |
Balance sheet
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Assets | $373.94M | $252.45M | $332.39M | $332.39M | $333.59M |
| Total Current Assets | $324.04M | $200.81M | $279.12M | $279.12M | $280.35M |
| Cash and Cash Equivalents & Short-Term Investments | $307.83M | $195.33M | $268.89M | $268.89M | $269.14M |
| -Cash and Cash Equivalents | $307.83M | $185.36M | $209.02M | $209.02M | $122.95M |
| -Short Term Investments | $0.00 | $9.97M | $59.87M | $59.87M | $146.19M |
| Receivables | $0.00 | $0.00 | $1.62M | $1.62M | $2.96M |
| Inventory | $9.87M | – | – | – | – |
| Other Current Assets | $6.34M | $5.48M | $8.61M | $8.61M | $8.26M |
| Total Non-Current Assets | $49.91M | $51.64M | $53.27M | $53.27M | $53.24M |
| Net PPE | $44.73M | $46.70M | $48.62M | $48.62M | $50.33M |
| -Gross PPE | $63.17M | $64.37M | $65.36M | $65.36M | $66.29M |
| -Accumulated Depreciation | -$18.44M | -$17.67M | -$16.73M | -$16.73M | -$15.96M |
| Other Non-Current Assets | $5.18M | $4.94M | $4.65M | $4.65M | $2.90M |
| Total Liabilities | $169.16M | $146.80M | $166.23M | $166.23M | $123.05M |
| Total Current Liabilities | $45.55M | $38.41M | $58.23M | $58.23M | $50.09M |
| Payables | $5.96M | $4.26M | $6.67M | $6.67M | $5.65M |
| -Accounts Payable | $5.96M | $4.26M | $6.67M | $6.67M | $5.65M |
| Current Accrued Expenses | $22.90M | $22.95M | $27.28M | $27.28M | $24.68M |
| Short-Term Debt and Capital Lease Obligation | $4.04M | $4.04M | $4.04M | $4.04M | $4.08M |
| -Current Capital Lease Obligation | $4.04M | $4.04M | $4.04M | $4.04M | $4.08M |
| Other Current Liabilities | $3.91M | $2.04M | $2.76M | $2.76M | $1.24M |
| Total Non-Current Liabilities | $123.61M | $108.39M | $108.00M | $108.00M | $72.96M |
| Long Term Debt and Capital Lease Obligation | $123.15M | $107.94M | $107.55M | $107.55M | $72.27M |
| -Long Term Debt | $99.77M | $84.11M | $83.31M | $83.31M | $47.63M |
| -Long Term Capital Lease Obligation | $23.39M | $23.82M | $24.24M | $24.24M | $24.64M |
| Other Non-Current Liabilities | $455,000.00 | $455,000.00 | $455,000.00 | $455,000.00 | $693,000.00 |
| Total Equity | $204.78M | $105.65M | $166.16M | $166.16M | $210.54M |
| Stockholders' Equity | $204.78M | $105.65M | $166.16M | $166.16M | $210.54M |
| Capital Stock | $95,000.00 | $84,000.00 | $82,000.00 | $82,000.00 | $79,000.00 |
| -Common Stock | $95,000.00 | $84,000.00 | $82,000.00 | $82,000.00 | $79,000.00 |
| Additional Paid-In Capital | $1.59B | $1.43B | $1.42B | $1.42B | $1.39B |
| Retained Earnings | -$1.39B | -$1.33B | -$1.26B | -$1.26B | -$1.19B |
| Gains/Losses Not Affecting Retained Earnings | $5.92M | $5.98M | $5.40M | $5.40M | $5.56M |
| -Other Receivables | – | – | $1.62M | $1.62M | $2.96M |
Cash flow
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$47.70M | -$75.73M | -$280.34M | -$56.16M | -$65.96M |
| Net cash flow from continuing operations | -$47.70M | -$75.73M | -$280.34M | -$56.16M | -$65.96M |
| Net Income from Continuing Operations | -$57.12M | -$69.77M | -$313.94M | -$73.22M | -$70.93M |
| Gain/Loss from Continuing Operations | $67,000.00 | -$688,000.00 | -$942,000.00 | -$77,000.00 | -$581,000.00 |
| Depreciation & Depletion & Amortization | $773,000.00 | $937,000.00 | $3.33M | $769,000.00 | $848,000.00 |
| Other Non-Cash Items | $1.47M | $1.62M | $5.13M | $1.49M | $1.23M |
| Change in Working Capital | -$4.18M | -$15.50M | -$3.84M | $6.88M | -$3.43M |
| -Change in Receivables | -$233,000.00 | $1.35M | $451,000.00 | -$464,000.00 | -$349,000.00 |
| -Change in Prepaid Assets | -$851,000.00 | $3.13M | -$232,000.00 | -$362,000.00 | $36,000.00 |
| -Change in Payables and Accrued Expense | $7.00M | -$19.76M | -$2.76M | $7.82M | -$2.64M |
| -Change in Other Current Liabilities | -$226,000.00 | -$218,000.00 | -$1.31M | -$116,000.00 | -$475,000.00 |
| Net cash flow from investing | $9.76M | $49.99M | $310.84M | $86.51M | $75.12M |
| Net Cash Flow from Continuing Investing Activities | $9.76M | $49.99M | $310.84M | $86.51M | $75.12M |
| Net PPE Purchase and Sale | $3,000.00 | -$6,000.00 | -$4.22M | -$5,000.00 | -$135,000.00 |
| Net Investment Purchase and Sale | $9.76M | $50.00M | $315.07M | $86.51M | $75.26M |
| Financing Cash Flow | $160.55M | $800,000.00 | $66.29M | $55.68M | $10.45M |
| Net Cash Flow from Continuing Financing Activities | $160.55M | $800,000.00 | $66.29M | $55.68M | $10.45M |
| Net Issuance Payments Of Debt | $14.79M | -$203,000.00 | $34.26M | $34.80M | -$195,000.00 |
| Proceeds from Stock Option Exercised | $35.78M | $1.00M | $883,000.00 | $92,000.00 | $282,000.00 |
| Ending Cash Balance | $309.54M | $187.06M | $210.73M | $210.73M | $124.66M |
| Net Change in Cash | $122.61M | -$24.94M | $96.79M | $86.02M | $19.62M |
| Beginning Cash Balance | $187.06M | $210.73M | $112.82M | $124.66M | $104.00M |
| Effect of Exchange Rate Changes | -$136,000.00 | $1.27M | $1.11M | $50,000.00 | $1.04M |
| Free Cash Flow | -$47.78M | -$75.73M | -$284.57M | -$56.17M | -$66.09M |
| -Change in Other Current Assets | – | – | $0.00 | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | $31.15M | $20.78M | $10.36M |
No comments yet — be the first to weigh in on REPL.
Sign in to join the discussion.